• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, August 3, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Ross Prize in Molecular Medicine to be awarded to Dr. Jeffrey V. Ravetch

Bioengineer by Bioengineer
May 30, 2017
in Biology
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

NEW YORK, May 30, 2017 – The New York Academy of Sciences in conjunction with the Feinstein Institute for Medical Research and Molecular Medicine will host the 2017 Ross Prize in Molecular Medicine – Regulating Immunity: Fc Receptor Biology at the Academy's headquarters on Monday, June 5th. Pioneering immunology researcher Jeffrey V. Ravetch MD, PhD, the Theresa and Eugene M. Lang Professor and Head of the Leonard Wagner Laboratory of Molecular Genetics and Immunology at The Rockefeller University, will be awarded this year's prize, which includes a $50,000 award for his identification of the mechanism by which the specific structure of antibodies controls immune cell reactivity.

"I am honored by the recognition this award represents and to be included among the distinguished scientists who have preceded me," said Dr. Ravetch on the news of his receiving the award.

Dr. Ravetch's research focuses on understanding the immune system response. His work revealed the fine line that exists between healthy immune reactions that destroy foreign pathogens, and autoimmunity that attacks the body's own tissue. This understanding and improved knowledge of immunity will allow for the improvement or creation of new therapies for infectious, neoplastic, and inflammatory diseases.

The Ross Prize recognizes biomedical scientists who have made a significant impact in the understanding of human disease pathogenesis and/or treatment, and who hold significant promise for making even greater contributions to the general field of molecular medicine.

"Dr. Jeffrey Ravetch's discovery of the relationship between antibodies and activation of the immune response has opened the door to developing new therapies for autoimmune conditions," said Feinstein Institute President and CEO Kevin J. Tracey, MD, who also serves as editor emeritus of Molecular Medicine. "His work embodies the pioneering spirit of the Ross Prize and we look forward to honoring his career and to his future discoveries' positive impact on patients."

After the presentation ceremony, Dr. Ravetch will give a lecture titled, "Diversification of Antibody Effector Function," where he will discuss his findings in the field of Fc Receptor Biology. In addition, Rafi Ahmed, PhD, Director of the Emory Vaccine Center, and Ronald Levy, MD, Professor and Chief of the Division of Oncology at Stanford Medicine, will discuss their work on antibody dependent mechanisms of protection in infectious disease and cancer.

###

If you are interested in attending this event in person please visit the registration page for additional information.

About the Feinstein Institute

The Feinstein Institute for Medical Research is the research arm of Northwell Health, the largest healthcare provider in New York. Home to 50 research laboratories and to clinical research throughout dozens of hospitals and outpatient facilities, the 3,500 researchers and staff of the Feinstein are making breakthroughs in molecular medicine, genetics, oncology, brain research, mental health, autoimmunity, and bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For more information about how we empower imagination and pioneer discovery, visit FeinsteinInstitute.org

About Molecular Medicine

Molecular Medicine is an Open-Access, international, peer-reviewed, biomedical journal seeking insight into the cellular and molecular basis of disease. The journal publishes work in the format of original research articles, review articles, editorials, commentaries and letters to the editor. The 2014 Journal Citation Report (JCR) lists Molecular Medicine with an impact factor of 4.508. For more information, visit http://www.molmed.org.

The New York Academy of Sciences

The New York Academy of Sciences is an independent, not-for-profit organization that since 1817 has been driving innovative solutions to society's challenges by advancing scientific research, education, and policy. With more than 20,000 Members in 100 countries, the Academy is creating a global community of science for the benefit of humanity. Please visit us online at http://www.nyas.org and follow us on Twitter at @NYASciences.

Media Contact

Robert Birchard
[email protected]
212-298-8689
@NYASEvents

############

Story Source: Materials provided by Scienmag

Share12Tweet7Share2ShareShareShare1

Related Posts

blank

CK2–PRC2 Signal Drives Plant Cold Memory Epigenetics

August 2, 2025
blank

AI-Driven Protein Design Advances T-Cell Immunotherapy Breakthroughs

August 1, 2025

Melanthiaceae Genomes Reveal Giant Genome Evolution Secrets

August 1, 2025

“Shore Wars: New Study Tackles Oyster-Mangrove Conflicts to Boost Coastal Restoration”

August 1, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    45 shares
    Share 18 Tweet 11
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

    38 shares
    Share 15 Tweet 10

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Inside Layer 5 Thick Tufted Neurons’ Synaptic Network

Long-Lived Ghost Phonon Polaritons via Selective Excitation

Whole-Exome Sequencing Reveals Schizophrenia Risk Genes

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.